1. A Low Dose of Pure Cannabidiol Is Sufficient to Stimulate the Cytotoxic Function of CIK Cells without Exerting the Downstream Mediators in Pancreatic Cancer Cells
   Francesca Garofano et al, 2022, International Journal of Molecular Sciences CrossRef
2. Inferring the diagnostic potential of 18F-FDG-PET/CT in post-renal transplantation from a unique case harboring multiple rare complications
   Zizhen Huang et al, 2024, Frontiers in Medicine CrossRef
3. Non-oncology drug (meticrane) shows anti-cancer ability in synergy with epigenetic inhibitors and appears to be involved passively in targeting cancer cells
   Yulu Wang et al, 2023, Frontiers in Oncology CrossRef
4. Clinical Studies on Cytokine-Induced Killer Cells: Lessons from Lymphoma Trials
   Ying Zhang et al, 2021, Cancers CrossRef
5. Development of PD-1 blockade peptide-cell conjugates to enhance cellular therapies for T-cell acute lymphoblastic leukemia
   Quanxiao Wang et al, 2023, Medical Oncology CrossRef
6. Recent Development in NKT-Based Immunotherapy of Glioblastoma: From Bench to Bedside
   Yutao Li et al, 2022, International Journal of Molecular Sciences CrossRef
7. A Combination of Cytokine-Induced Killer Cells With PD-1 Blockade and ALK Inhibitor Showed Substantial Intrinsic Variability Across Non-Small Cell Lung Cancer Cell Lines
   Yutao Li et al, 2022, Frontiers in Oncology CrossRef
8. High Complete Response Rate in Patients With Metastatic Renal Cell Carcinoma Receiving Autologous Cytokine-Induced Killer Cell Therapy Plus Anti-Programmed Death-1 Agent: A Single-Center Study
   Lingdi Zhao et al, 2022, Frontiers in Immunology CrossRef
9. CD4+ T cells are required to improve the efficacy of CIK therapy in non-small cell lung cancer
   Shaochuan Liu et al, 2022, Cell Death & Disease CrossRef